You just read:

Relievant Medsystems Receives FDA Approval to Begin Pivotal Study to Evaluate the Intracept System for Minimally Invasive Treatment of Chronic Low Back Pain

News provided by

RelievantMedsystems, Inc.

Aug 08, 2011, 08:00 ET